Echo Therapeutics' Unattributed VC - III Round

Echo Therapeutics raised a round of funding on October 21, 2003. Investors include Essex Woodlands.

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system…

Articles about Echo Therapeutics' Unattributed VC - III Round: